Literature DB >> 73640

Impaired red cell deformability in peripheral vascular disease.

H L Reid, J A Dormandy, A J Barnes, P J Lock, T L Dormandy.   

Abstract

By means of a recently developed technique, red-cell deformability was measured in 44 patients with peripheral vascular disease and in 44 age and sex matched normal control subjects. 28 patients had intermittent claudication and 16 rest pain or gangrene. The ability of the red cells to deform was significantly reduced in patients and significantly less in patients with rest pain or gangrene than in those who only had intermittent claudication. A reduction in red-cell deformability by retarding blood-flow through the microcirculation may be an important factor in states of peripheral vascular insufficiency.

Entities:  

Mesh:

Year:  1976        PMID: 73640     DOI: 10.1016/s0140-6736(76)92778-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Can drug therapy alter the natural course of peripheral vascular disease?: a review.

Authors:  C A Clyne
Journal:  Proc R Soc Med       Date:  1977

2.  Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease.

Authors:  T Di Perri; S Forconi; M Guerrini; F L Pasini; R Del Cipolla; C Rossi; D Agnusdei
Journal:  Proc R Soc Med       Date:  1977

Review 3.  The clinical importance of erythrocyte deformability, a hemorrheological parameter.

Authors:  F C Mokken; M Kedaria; C P Henny; M R Hardeman; A W Gelb
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

4.  Pentoxifylline in arterial disease of the legs.

Authors:  R Verhaeghe; M Verstraete
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  A simple method for measuring erythrocyte deformability.

Authors:  H L Reid; A J Barnes; P J Lock; J A Dormandy; T L Dormandy
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

Review 6.  Drugs that alter blood viscosity. Their role in therapy.

Authors:  A M Ehrly
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

7.  [Predictor function of hemorheologic parameters with reference to the incidence of manifest circulatory disorders: Concept of the Aachen study].

Authors:  H Kiesewetter; F Jung; K H Ladwig; E Waterloh; P Roebruck; R Schneider; G Kotitschke; R Bach
Journal:  Klin Wochenschr       Date:  1986-07-15

8.  Influence of cyclandelate on in vitro red blood cell deformability.

Authors:  D W Hall; W E van den Hoven
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  [Changes in the blood rheology and their influence on the oxygen diffusion in normal and pathological pregnancies (author's transl)].

Authors:  L Heilmann; C Mattheck; E Kurz
Journal:  Arch Gynakol       Date:  1977-11-29

10.  Pentoxifylline does not reduce infarct size in a canine model of acute myocardial infarction.

Authors:  C A Campbell; C F Clavenna; J Wynne; R A Kloner
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.